Description

Join us for a deep dive into the dynamic world of obesity management with Dr. Terri-Lynne South, Chair of the Royal Australian College of General Practitioners' Obesity Medicine Group. In this episode, Dr. South shares her expertise on the revolutionary impact of semaglutide and other GLP1 receptor agonists in combating chronic obesity. From mechanisms of action to clinical considerations, discover how these medications are reshaping treatment paradigms and empowering healthcare professionals to provide comprehensive care for patients struggling with obesity.

Key Highlights:

• Dr. South's personal journey from dietitian to medical doctor and her passion for metabolic health.
• The transformative role of semaglutide and GLP1 agonists in obesity management.
• Insights into the pharmacological mechanisms and metabolic benefits of these medications.
• Considerations for healthcare professionals, including patient education, side effects management, and long-term treatment strategies.
• The importance of holistic approaches integrating pharmacotherapy and lifestyle interventions for sustained health outcomes.

Tune in to gain invaluable insights from Dr. Terri-Lynne South and explore the evolving landscape of obesity management on Spotify.